The Global Fund and COVID-19
Learn how the Global Fund is tackling COVID-19 to protect progress on AIDS, TB and malaria, including the new COVID-19 Response Mechansim.
COVID-19 is Threatening Progress on AIDS, TB and Malaria
The COVID-19 pandemic is having a catastrophic impact on the most vulnerable communities worldwide and threatens progress against HIV, TB and malaria.
Subscribe to receive updates
The Global Fund to Fight AIDS, Tuberculosis and Malaria: A smart, lifesaving U.S. investment
U.S. investments in the Global Fund provide significant health security and economic benefits
Grows export markets
Catalyzes domestic investments in health
Helps contain emerging pandemics
CHALLENGES
Insecticide Resistance
Antibiotic Resistance
Young Women at Risk
Growing Youth populations
FEATURED
Report: End the AIDS Epidemic
Translating Progress into Success to End the AIDS Epidemic is a collaboration between amfAR, AVAC, and Friends of the Global Fight, with technical assistance from the Henry J. Kaiser Family Foundation. The report was conceptualized to take stock of how far we have come – and how far we have to go – toward ending HIV and AIDS around the world.
INFOGRAPHIC: What does $1.56 billion buy?
In 2019, the whole world stepped up, pledging $14 billion for the Global Fund’s hugely successful sixth Replenishment – an unprecedented 15 percent increase over the previous fundraising cycle. U.S. leadership was instrumental, encouraging other donors to increase their contributions and get the world back on track to end AIDS, TB and malaria.
Infographic: The Global Fund – Scaling Innovations in Global Health Since 2002
The Global Fund to Fight AIDS, Tuberculosis and Malaria is the world’s largest global health funder and has saved 32 million lives since its founding in 2002. Below are just a few examples of how the Global Fund has helped scale innovative treatment, prevention and diagnostic technologies over the past 18 years.
Infographic: U.S. AIDS, TB and Malaria Investments and Pandemic Preparedness
How U.S. investments in the global fight to end AIDS, TB and malaria help prepare the world to identify and respond to emerging pandemics.
LEARN MORERECENT NEWS
How COVID-19 is affecting the global response to AIDS, tuberculosis and malaria
The COVID-19 pandemic is having a serious impact on the most vulnerable communities worldwide and threatens progress on HIV, TB, malaria, vaccination and other areas of health. Below, you can find regularly updated information on the impact of COVID-19 on HIV/AIDS, TB and malaria and news items from around the world on important developments. 1….
Webinar: The Impacts of COVID-19 on AIDS, Tuberculosis & Malaria Programs in Africa
On July 14, Friends of the Global Fight Against AIDS, Tuberculosis and Malaria hosted an online webinar to discuss the impact of COVID-19 on global HIV, TB, and malaria programs in Africa. The webinar highlights: 1. What we know from evidence and experience about the impact of COVID-19 on HIV/AIDS, TB, and malaria thus far,…
The Global Fund: At the Leading Edge of the Global Response to COVID-19
The Global Fund to Fight AIDS, Tuberculosis and Malaria: At the Leading Edge of the Global Response to COVID-19 The COVID-19 pandemic threatens to reverse extraordinary gains made in the fight against the epidemics of AIDS, tuberculosis and malaria. The United States should be proud of our leading role in addressing these epidemics but COVID-19…
Friends applauds House Appropriations Committee for maintaining U.S. contribution to Global Fund, COVID-19
Friends applauds House Appropriations Committee for maintaining the U.S. contribution to the Global Fund and responding to COVID-19 globally Washington, DC – Friends applauds the House Appropriations Committee for sustaining support for the Global Fund to Fight AIDS, Tuberculosis and Malaria at $1.56 billion in its fiscal year 2021 State, Foreign Operations, and Related Programs…
Private Sector Calls for Global Action on Pandemic in Next Supplemental Appropriation
Private Sector Calls for Global Action on Pandemic in Next Supplemental Appropriation The Honorable Mitch McConnell Majority Leader United States Senate S-230, U.S. Capitol Washington, D.C. 20510 The Honorable Charles Schumer Minority Leader United States Senate S-220, U.S. Capitol Washington, D.C. 20510 The Honorable Nancy Pelosi Speaker of the House United States House of Representatives…